ADRIAMYCIN OR DAUNORUBICIN IN COMBINATION WITH CYTOSINE-ARABINOSIDE FOR THE TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
WIERNIK, PH [1 ]
RIGGS, C [1 ]
DUTCHER, JP [1 ]
机构：
[1] BALTIMORE CANC RES CTR, BALTIMORE, MD 21211 USA
来源：
DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 1983年 / 9卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：403 / 406
页数：4
相关论文
共 50 条
  • [31] A COMPARISON OF 2 SCHEDULES OF CYTOSINE-ARABINOSIDE USED IN COMBINATION WITH ADRIAMYCIN AND 6-THIOGUANINE IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA
    SLEVIN, ML
    ROHATINER, AZS
    DHALIWAL, HS
    HENRY, GP
    BELL, R
    LISTER, TA
    MEDICAL AND PEDIATRIC ONCOLOGY, 1982, : 185 - 192
  • [32] CYTOSINE-ARABINOSIDE TRANSPORT AND CYTOSINE-ARABINOSIDE TRIPHOSPHATE FORMATION IN ACUTE-LEUKEMIA
    TAUPIN, JM
    WILEY, JS
    SAWYER, WH
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1983, 10 (04) : 435 - 435
  • [33] LEVAMISOLE (L), CYTOSINE-ARABINOSIDE (ARA-C), AND DAUNORUBICIN (DNR) INDUCTION THERAPY OF ADULT ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL)
    CHANG, P
    WIERNIK, PH
    LICHTENFELD, JL
    SCHIFFER, CA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 370 - 370
  • [34] CYTOSINE-ARABINOSIDE MANAGEMENT OF ACUTE LEUKEMIA
    HAAB, O
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1968, 98 (15) : 590 - &
  • [35] HIGH-DOSE CYTOSINE-ARABINOSIDE AND DAUNORUBICIN AS CONSOLIDATION THERAPY FOR ACUTE NONLYMPHOCYTIC LEUKEMIA IN 1ST REMISSION - AN UPDATE
    WOLFF, SN
    HERZIG, RH
    PHILLIPS, GL
    LAZARUS, HM
    GREER, JP
    STEIN, RS
    RAY, WA
    HERZIG, GP
    SEMINARS IN ONCOLOGY, 1987, 14 (02) : 12 - 17
  • [36] TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL) USING 3 DOSES OF ADRIAMYCIN (ADR) AND A 10-DAY INFUSION OF CYTOSINE-ARABINOSIDE (ARA C)
    PREISLER, H
    HENDERSON, E
    HRYNIAK, W
    HIGBY, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 297 - 297
  • [37] TREATMENT OF POOR RISK ACUTE NONLYMPHOCYTIC LEUKEMIA WITH CONTINUOUSLY INFUSED LOW-DOSE CYTOSINE-ARABINOSIDE
    BALABAN, EP
    COX, JV
    SCHNEIDER, NR
    HARTH, CA
    HALEY, BB
    SHEEHAN, R
    FRENKEL, EP
    AMERICAN JOURNAL OF HEMATOLOGY, 1988, 29 (02) : 79 - 84
  • [38] PREDICTION OF RESPONSE OF ACUTE NONLYMPHOCYTIC LEUKEMIA TO THERAPY WITH HIGH-DOSE CYTOSINE-ARABINOSIDE
    PREISLER, HD
    EPSTEIN, J
    BARCOS, M
    PRIORE, R
    RAZA, A
    BROWMAN, GP
    VOGLER, R
    WINTON, E
    GRUNWALD, H
    RAI, K
    BRENNAN, J
    BENNETT, J
    GOLDBERG, J
    GOTTLIEB, A
    CHERVENICK, P
    JOYCE, R
    MILLER, K
    LARSON, R
    DARRIGO, P
    DOEBLIN, T
    STEIN, M
    BLOOM, M
    STEELE, R
    LEE, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1984, 58 (01) : 19 - 32
  • [39] HIGH-DOSE CYTOSINE-ARABINOSIDE WITH AND WITHOUT ANTHRACYCLINE IN REFRACTORY ACUTE NONLYMPHOCYTIC LEUKEMIA
    HERZIG, RH
    HERZIG, GP
    LAZARUS, HM
    WOLFF, SN
    PHILLIPS, GL
    CLINICAL RESEARCH, 1982, 30 (04): : A783 - A783
  • [40] RESULTS OF A RANDOMIZED TRIAL COMPARING IDARUBICIN AND CYTOSINE-ARABINOSIDE WITH DAUNORUBICIN AND CYTOSINE-ARABINOSIDE IN ADULT PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA
    BERMAN, E
    HELLER, G
    SANTORSA, J
    MCKENZIE, S
    GEE, T
    KEMPIN, S
    GULATI, S
    ANDREEFF, M
    KOLITZ, J
    GABRILOVE, J
    REICH, L
    MAYER, K
    KEEFE, D
    TRAINOR, K
    SCHLUGER, A
    PENENBERG, D
    RAYMOND, V
    OREILLY, R
    JHANWAR, S
    YOUNG, C
    CLARKSON, B
    BLOOD, 1991, 77 (08) : 1666 - 1674
12345